GENE ONLINE|News &
Opinion
Blog

HIV
Gilead Touts Long-Term Efficacy And Safety Data For HIV Drug
2022-10-26
Merck’s Phase 2 HIV Treatment Study Resumes with Phase 3 Program Announcement
2022-09-20
A Cure for HIV Could Be Here Sooner Than You Think – Future of Health
2022-09-16
Gilead’s Novel Capsid Inhibitor Treatment for HIV Gains First Approval from European Commission
2022-08-22
HIV Latent Cells Could Lead to Possible Cure
2022-07-28
Ascletis Begins Study of PD-L1 Antibody Candidate Against HIV
2022-07-04
This One-Time Injection Could Cure AIDS
2022-06-21
FDA Allows Resumption of Gilead’s Lenacapavir AIDS Trials
2022-05-19
GeneOnline’s Top 10 Editor’s Picks for 2021
2021-12-23
FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention
2021-12-22
Experimental mRNA Vaccine Could Lead Fight Against HIV
2021-12-19
A Digital Solution Tracks Pill Adherence with 98% Accuracy
2021-12-13
Samsung Biologics Inks CDMO Deal with Enzolytics on HIV and COVID-19 Antibodies
2021-10-08
J&J’s HIV Vaccine Results Disappoint, Trial Halted But Search Continues
2021-09-01
Gilead, Merck Unite to Contest ViiV’s Cabenuva with Long-Acting HIV Therapy
2021-03-16
1 2
LATEST
NDA for Biogen-Sage’s Zuranolone Accepted by FDA, Marking Another Step Forward in Depression Drug Development
2023-02-07
BMS Returns $475 Million Cancer Asset To Dragonfly Therapeutics
2023-02-07
FDA Expands Approval For Takeda’s Takhzyro To Prevent Hereditary Angioedema Attacks
2023-02-06
Abbott’s New Technologies for Arrhythmia Treatment Secure FDA and European Approval
2023-02-04
First Human Trial for Marburg Virus Vaccine Reports Success
2023-02-03
Karuna Licenses Goldfinch’s Mood Disorder Candidates For Potential $535 Million
2023-02-03
Novel Bioengineered Wearable Edgeless Skin Brings Hope to Revolutionize Plastic and Reconstructive Surgery
2023-02-03
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!